Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM

NCT01160237 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.

Conditions

Interventions

Sponsor

GlaxoSmithKline